A Longitudinal Comparison of Alternatives to Body Mass Index Z-Scores for Children with Very High Body Mass Indexes.


Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
08 2021
Historique:
received: 12 11 2020
revised: 25 02 2021
accepted: 26 02 2021
pubmed: 8 3 2021
medline: 9 11 2021
entrez: 7 3 2021
Statut: ppublish

Résumé

The current Centers for Disease Control and Prevention (CDC) body mass index (BMI) z-scores are inaccurate for BMIs of ≥97th percentile. We, therefore, considered 5 alternatives that can be used across the entire BMI distribution: modified BMI-for-age z-score (BMIz), BMI expressed as a percentage of the 95th percentile (%CDC95th percentile), extended BMIz, BMI expressed as a percentage of the median (%median), and %median adjusted for the dispersion of BMIs. We illustrate the behavior of the metrics among children of different ages and BMIs. We then compared the longitudinal tracking of the BMI metrics in electronic health record data from 1.17 million children in PEDSnet using the intraclass correlation coefficient to determine if 1 metric was superior. Our examples show that using CDC BMIz for high BMIs can result in nonsensical results. All alternative metrics showed higher tracking than CDC BMIz among children with obesity. Of the alternatives, modified BMIz performed poorly among children with severe obesity, and %median performed poorly among children who did not have obesity at their first visit. The highest intraclass correlation coefficients were generally seen for extended BMIz, adjusted %median, and %CDC95th percentile. Based on the examples of differences in the BMI metrics, the longitudinal tracking results and current familiarity BMI z-scores and percentiles. Both extended BMIz and extended BMI percentiles may be suitable replacements for the current z-scores and percentiles. These metrics are identical to those in the CDC growth charts for BMIs of <95th percentile and are superior for very high BMIs. Researchers' familiarity with the current CDC z-scores and clinicians with the CDC percentiles may ease the transition to the extended BMI scale.

Identifiants

pubmed: 33676932
pii: S0022-3476(21)00211-0
doi: 10.1016/j.jpeds.2021.02.072
pii:
doi:

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

156-162

Commentaires et corrections

Type : CommentIn
Type : CommentOn

Informations de copyright

Published by Elsevier Inc.

Auteurs

David S Freedman (DS)

Division of Nutrition, Physical Activity, and Obesity, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: dxf1@cdc.gov.

Amy J Goodwin Davies (AJG)

Applied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, PA.

Lyudmyla Kompaniyets (L)

Division of Nutrition, Physical Activity, and Obesity, Centers for Disease Control and Prevention, Atlanta, GA.

Samantha J Lange (SJ)

Division of Nutrition, Physical Activity, and Obesity, Centers for Disease Control and Prevention, Atlanta, GA.

Alyson B Goodman (AB)

Division of Nutrition, Physical Activity, and Obesity, Centers for Disease Control and Prevention, Atlanta, GA.

Thao-Ly Tam Phan (TT)

Department of Pediatrics, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE.

F Sessions Cole (FS)

Department of Pediatrics, Washington University School of Medicine, St Louis, MO.

Amanda Dempsey (A)

Department of Pediatrics, University of Colorado, Aurora, CO.

Nathan Pajor (N)

Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH.

Ihuoma Eneli (I)

Nationwide Children's Hospital, Columbus, OH.

Dimitri A Christakis (DA)

Seattle Children's Research Institute, University of Washington, Seattle, WA.

Christopher B Forrest (CB)

Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH